UK Hypodermic Syringes And Needles Market To Reach $479.3 Million By 2030

UK Hypodermic Syringes And Needles Market Growth & Trends

The UK hypodermic syringes and needles market size is anticipated to reach USD 479.3 million by 2030, expanding at a CAGR of 16.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth can be attributed to factors such as the growing geriatric population, increasing prevalence of chronic disorders, and rising number of surgeries. Increasing demand for syringes for mass vaccination is the primary factor driving the demand for hypodermic syringes and needles. Moreover, an increasing number of needlestick injuries is expected to drive the market growth. According to a National Library of Medicine study published in April 2024, approximately 100,000 needlestick injuries occur annually in the UK.

Furthermore, enhancing the efficacy and safety of anesthetic administration are the growing technological developments in syringes and needle designs. The market is expanding due to innovations, including safety-engineered syringes, ultra-thin needles, and smart syringes with integrated technology. These developments aid in patient comfort, improving accuracy and lowering problems, which makes it easier for patients to accept innovative products.

Furthermore, the need for hypodermic needles and syringes is fueled by the UK's advanced healthcare system, which is comprised of modern hospitals and clinics. Investments made to modernize and enlarge medical facilities result in higher use of these hypodermic syringes. The National Health Service (NHS) finances healthcare services, which makes it easier to buy hypodermic syringes, and other contemporary medical equipment.

UK regulations demand that hypodermic syringes and needles meet high standards for patient safety, sterility, and quality. Manufacturers must adhere to guidelines set by regulatory bodies such as the Medicines and Healthcare Products Regulatory Agency (MHRA) and European Medical Device Regulation (MDR), which increase the cost and complexity of the approval process. The process of obtaining approval for medical devices such as hypodermic syringes and needles can be time-consuming due to the need for clinical testing, safety evaluations, and risk assessments.

 Request a free sample copy or view report summary: UK Hypodermic Syringes And Needles Market Report

UK Hypodermic Syringes And Needles Market Report Highlights

• Based on product, the hypodermic syringes segment held the largest market share in 2023. This is attributed to the quick technical developments that increase patient comfort, safety, and effectiveness during medical procedures

• Based on end use, the hospitals segment dominated the market with the largest revenue share in 2023. This is due to their crucial role in maintaining a consistent and high demand for hypodermic needles and syringes, primarily due to the extensive number of medical procedures carried out

UK Hypodermic Syringes And Needles Market Segmentation

Grand View Research has segmented the UK hypodermic syringes and needles market on the basis of product, and end-use.

UK Hypodermic Syringes And Needles Product Outlook (Revenue, USD Million, 2018 - 2030)

• Hypodermic Syringes

  • Conventional Syringes

  • Safety Syringes

    • Retractable Safety Syringes

    • Non-retractable Safety Syringes

• Hypodermic Needles

  • Conventional Needles

  • Safety Needles

UK Hypodermic Syringes And Needles End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Clinics

• Ambulatory Surgical Centers

• Veterinary

• Home Care

• Others

List of key players in the UK Hypodermic Syringes And Needles Market

• BD (Becton, Dickinson & Corporation)

• Cardinal Health

• B. Braun SE

• ICU Medical

• Terumo Corporation

• Nipro Europe Group Companies (Nipro Corporation)

• SolM

• GBUK Group Ltd.